Merz Therapeutics GmbH

Headache Disorders

Clinical research includes prevention-focused studies in episodic migraine and chronic migraine, with attention to reducing migraine burden and improving symptom control in affected adults.

  • Chronic migraine
  • Episodic migraine
  • Monthly migraine days

The sponsor’s work in this area is centered on injectable therapies evaluated for migraine prevention across both episodic and chronic forms of the disorder.

Neuropathic Pain

Another key area is moderate to severe chronic peripheral neuropathic pain, including pain associated with postherpetic neuralgia and peripheral nerve injury, where research is directed toward relief of persistent pain symptoms.

  • Peripheral neuropathic pain
  • Postherpetic neuralgia
  • Peripheral nerve injury

These studies reflect interest in conditions with ongoing sensory pain and functional impact in adult patients.

Injectable Neuromodulatory Therapies

The portfolio includes research on botulinum toxin-based injections used in neurological and pain-related disorders, with clinical interest spanning both migraine prevention and neuropathic pain management.

  • Xeomin
  • NT 201
  • Injection-based treatment

This therapeutic domain links neurology and pain medicine through locally administered treatment approaches.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients

    Recruiting

    3 1 1
    Austria Czechia Denmark France Germany Italy +3
  • Study of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks

    Recruiting

    3 1 1
    Austria Czechia Denmark France Germany Italy +3
  • Study on the Effectiveness and Safety of NT 201 Injections for Adults with Chronic Neuropathic Pain from Postherpetic Neuralgia or Nerve Injury

    Not recruiting

    2 1 1
    Bulgaria France Germany Hungary Poland Spain